ImmunityBio, Inc. (IBRX)

ImmunityBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	143.43	265.45	104.64	181.1	34.92
Short-Term Investments	6.38	1.01	2.54	136.02	61.15
Cash & Short-Term Investments	149.81	266.46	107.18	317.12	96.06
Cash Growth	-43.78%	148.60%	-66.20%	230.12%	49.28%
Accounts Receivable	2.36	-	-	-	-
Other Receivables	0.29	3.17	1.89	1.33	2
Receivables	2.65	3.17	1.89	1.33	2
Inventory	8.27	-	2.16	-	-
Prepaid Expenses	23.85	12.87	14.74	12.25	13.65
Other Current Assets	-	11.59	14.6	3.65	-
Total Current Assets	184.59	294.08	140.58	334.35	111.71
Property, Plant & Equipment	170.46	182.68	189.58	119.17	90.68
Long-Term Investments	-	0.89	0.84	7.6	11.4
Other Intangible Assets	15.93	17.09	20	1.42	1.46
Other Long-Term Assets	4.83	2.82	4.73	-	-
Total Assets	382.93	504.45	362.36	468.91	221.38
Accounts Payable	6.73	9.2	21.02	11.42	11.51
Accrued Expenses	40.58	39.53	34.23	33.94	33.99
Short-Term Debt	-	1.48	433.32	301.83	-
Current Portion of Leases	7.47	5.31	2.73	3.01	5.02
Other Current Liabilities	0.17	2.77	9.57	18.8	17.62
Total Current Liabilities	54.94	58.28	500.86	369	68.13
Long-Term Debt	461.88	836.95	241.27	306.35	254.35
Long-Term Leases	34.82	39.94	48.02	37.07	16.18
Long-Term Deferred Tax Liabilities	-	-	-	-	0.17
Other Long-Term Liabilities	319.42	155.21	22.03	0.41	1.04
Total Liabilities	871.06	1,090	812.18	712.82	339.87
Common Stock	0.09	0.07	0.04	0.04	0.04
Additional Paid-In Capital	2,885	2,375	1,931	1,720	1,495
Retained Earnings	-3,375	-2,962	-2,378	-1,962	-1,615
Comprehensive Income & Other	1.2	0.01	0.18	0	0.12
Total Common Equity	-489.1	-586.99	-447.33	-242.17	-119.81
Minority Interest	0.97	1.05	-2.49	-1.74	1.32
Shareholders' Equity	-488.13	-585.94	-449.82	-243.91	-118.49
Total Liabilities & Equity	382.93	504.45	362.36	468.91	221.38
Total Debt	504.17	883.68	725.33	648.26	275.55
Net Cash (Debt)	-354.36	-616.32	-617.31	-330.32	-178.54
Net Cash Per Share	-0.51	-1.21	-1.54	-0.85	-0.47
Filing Date Shares Outstanding	852.9	673.95	435.84	397.91	333.96
Total Common Shares Outstanding	852.9	670.87	421.57	397.83	333.96
Working Capital	129.64	235.8	-360.28	-34.65	43.58
Book Value Per Share	-0.57	-0.87	-1.06	-0.61	-0.36
Tangible Book Value	-505.03	-604.08	-467.33	-243.59	-121.27
Tangible Book Value Per Share	-0.59	-0.90	-1.11	-0.61	-0.36
Buildings	-	-	-	-	22.69
Machinery	-	71.8	69.85	55.34	35.75
Construction In Progress	-	84.44	72.69	16.58	1.33
Leasehold Improvements	-	72.55	68.71	62.48	52.25

Source: S&P Capital IQ. Standard template. Financial Sources.